埃拉斯通过诱导mTORC1-TFEB介导的自促使随机模式皮肤片的生存
Ximiao Chen1, Xuwei Zhu1, Yu Chen1
1Department of Orthopaedics, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang Province, China; Zhejiang Provincial Key Laboratory of Orthopedics, Wenzhou, Zhejiang Province, China; The Second School of Medicine, Wenzhou Medical University, Wenzhou, Zhejiang Province, China.
概括
低剂量埃拉斯通过通过mTORC1-TFEB调节的自来减少细胞死亡,从而保护皮肤片. 这种铁灭菌诱导体显示出提高随机模式皮肤片存活率的潜力.
科学领域:
- 再生医学是一种再生医学.
- 细胞生物学 细胞生物学
- 分子医学是分子医学.
背景情况:
- 随机图案的皮肤片对于重建至关重要,但由于营养供应不佳而患有远端缩.
- 埃拉斯,通常是一种铁灭菌诱导剂,在低剂量时表现出对内皮细胞中营养缺乏引起的细胞死亡的保护作用.
研究的目的:
- 研究低剂量埃拉斯保护内皮细胞免受营养缺乏症的机制.
- 在体内评估埃拉斯在提高随机图案皮肤片存活的治疗潜力.
主要方法:
- 人类静脉内皮细胞 (HUVEC) 在营养缺乏条件下用低剂量埃拉斯治疗.
- 进行RNA测序 (RNA-seq) 来分析基因表达变化.
- 在体内研究中,使用埃拉斯治疗具有随机模式皮肤片的小鼠,并评估片存活率, perfusion 和微血管密度.
主要成果:
- 低剂量埃拉斯 (2μM) 降低了营养缺乏的HUVEC细胞的细胞死亡,与自调节有关.
- 埃拉斯抑制了mTORC1并促进了TFEB活性,这表明mTORC1/TFEB通路在其保护作用中的作用.
- 在体内,埃拉斯治疗显著增加了随机模式皮肤生存区域,血液输液和微血管密度,在缺血区域增强了自.
结论:
- 低剂量埃拉斯通过mTORC1-TFEB介导的自来保护内皮细胞免受营养缺乏引起的死亡.
- 埃拉斯治疗是一种有前途的治疗策略,可以提高随机图案皮肤片的生存能力.
相关概念视频
01:22PI3K/mTOR/AKT Signaling Pathway
3.5K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.5K
03:03mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
01:19Clinical Applications of Epidermal Stem Cells
2.7K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
2.7K
02:38Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
01:07MAPK Signaling Cascades
5.4K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.4K
01:12Renewal of Skin Epidermal Stem Cells
2.5K
The skin is divided into epidermis, dermis, and hypodermis, the skin's outermost, middle, and inner layers. The human epidermal layer regularly undergoes renewal, where old, dead cells are replaced by new cells. Epidermal stem cells or EpiSCs divide and differentiate to restore the lost cells. For the renewal process, some EpiSCs continuously self-renew. In contrast, few others differentiate into transit-amplifying cells, which later form prickle or spinous cells, followed by granular...
2.5K